Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Sidhu MK et al. - Costs and effects of micafungin compare to those of caspofungin in the treatment of systemic Candida infections in the UK. The results indicate that micafungin is cost-effective compared to caspofungin, although the difference was not found to be significant.

Related Articles

The treatment of diabetic foot infections: focus on ertapenem
Vascular Health and Risk Management, 11/09/09    Relevance Score: 96%

Does Chlamydia pneumoniae Infection Trigger to Development of Asthma in Wheezy Infants
Journal of Asthma, 11/13/09    Relevance Score: 95%

Urinary tract infection: diagnosis, treatment and prevention
British Journal of Nursing, 10/27/09    Relevance Score: 94%

Pandemic preparedness - Risk management and infection control for all respiratory infection outbreaks
Australian Family Physician, 11/09/09    Relevance Score: 92%

Combating antibiotic resistance in urinary tract infection
Nurse Prescribing, 10/12/09    Relevance Score: 92%

Today in Antimicrobials...keeping you current

Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infection: a meta-analysis
Current Medical Research and Opinion, 12/17/09

Artesunate plus amodiaquine combination therapy: reviewing the evidence
Drug Development Research, 12/17/09

Is antibiotic prophylaxis effective in preventing urinary tract infections in patients with vesicoureteral reflux
Expert Review of Anti-infective Therapy, 12/17/09

Today in Pharmacoeconomics...keeping you current

Costs of hospital-based methadone maintenance treatment in HIV/AIDS control among injecting drug users in Indonesia
Health Policy, 12/16/09

Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
Cost Effectiveness and Resource Allocation, 12/15/09

Cost-effectiveness of single agent, uptitration and switching statin treatment strategies for lipid lowering in Sweden
Current Medical Research and Opinion, 12/14/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address